Anti-proliferative effect of levamisole on human myeloma cell lines in vitro

References

• Amery, W. K. 1977. Levamisole as an immunotherapeutic agent in the treatment of cancer. World J. Surg. 1:597–604.
   PubMedGoogle Scholar
• Artwohl, M., Hölzenbein, T., Wagner, L., Freudenthaler, A., Waldhäusl, W. and Baumgartner-Parzer, S. M. 2000. Levamisole-induced apoptosis in cultured vascular endothelial cells. Br. J. Pharmacol. 131:1577–1583.
   PubMed Web of Science ®Google Scholar
• Bhuyan, A. K., Varshney, A. and Mathew, M. K. 2001. Resting membrane potential as a marker of apoptosis: Studies on Xenopus oocytes microinjected with cytochrome c. Cell Death Differ. 8:63–69.
   PubMedGoogle Scholar
• Borgers, M. 1973. The cytochemical application of new potent inhibitors of alkaline phosphatases. J. Histochem. Cytochem. 21:812–824.
   PubMed Web of Science ®Google Scholar
• Cafiero, F., Gipponi, M., Peressini, A., Bertoglio, S. and Lionetto, R. 2000. Preliminary analysis of a randomized clinical trial of adjuvant postoperative RT vs. postoperative RT plus 5-FU and levamisole in patients with TNM Stage II-III resectable rectal cancer. J. Surg. Oncol. 75:80–88.
   PubMedGoogle Scholar
• De Broe, M. E. and Van Hoof, V. O. 1991. Multiple forms of alkaline phosphatase in plasma of hemodialysis patients. Clin. Chem. 37:783–784.
   PubMedGoogle Scholar
• de Waard, J. W., de Man, B. M., Wobbes, T., van der Linden, C. J. and Hendriks, T. 1998. Inhibition of fibroblast collagen synthesis and proliferation by levamisole and 5-fluorouracil. Eur. J. Cancer. 34:162–167.
   PubMedGoogle Scholar
• Garba, M. T. and Marie, P. J. 1986. Alkaline phosphatase inhibition by levamisole prevents 1,25-dihydroxyvitamin D3-stimulated bone mineralization in the mouse. Calcif. Tissue Int. 38:296–302.
   PubMedGoogle Scholar
• Gum, J. R., Hicks, J. W., Sack, T. L. and Kim, Y. S. 1990. Molecular cloning of complementary DNAs encoding alkaline phosphatase in human colon cancer cells. Cancer Res. 50:1085–1091.
   PubMedGoogle Scholar
• Herz, F. 1985. Alkaline phosphatase isozymes in cultured human cancer cells. Experientia 41:1357–1361.
   PubMedGoogle Scholar
• Kim, J. A., Kang, Y. S., Lee, S. H., Lee, E. H., Yoo, B. H. and Lee, Y. S. 1999. Glibenclamide induces apoptosis through inhibition of cystic fibrosis transmembrane conductance regulator (CFTR) Cl− channels and intracellular Ca2+ release in HepG2 human hepatoblastoma cells. Biochem. Biophys. Res. Commun. 261:682–688.
   PubMed Web of Science ®Google Scholar
• Latham, K. M. and Stanbridge, E. J. 1990. Identification of the HeLa tumor-associated antigen, p75/150, as intestinal alkaline phosphatase and evidence for its transcriptional regulation. Proc. Natl. Acad. Sci. U.S.A. 87:1263–1267.
   PubMedGoogle Scholar
• Liu, X., Kim, C. N., Yang, J., Jemmerson, R. and Wang, X. 1996. Induction of apoptotic program in cell-free extracts: requirement for dATP and cytochrome c. Cell 86:147–157.
   PubMed Web of Science ®Google Scholar
• Liu, C. Y., Lai, Y. Y. and Lo, C. J. 2004. Levamisole modulates prostaglandin E2 production and cyclooxygenase II gene expression in human colonic cancer cells. J. Surg. Res. 117:223–231.
   PubMedGoogle Scholar
• Marty, L. M. and Feldbush, T. L. 1993. Effect of anti-alkaline phosphatase monoclonal antibody on B-lymphocyte function. Immunol. Lett. 38:87–95.
   PubMedGoogle Scholar
• Matsumoto, H., Erickson, R. H., Gum, J. R., Yoshioka, M., Gum, E. and Kim, Y. S. 1990. Biosynthesis of alkaline phosphatase during differentiation of the human colon cancer cell line Caco-2. Gastroenterology 98:1199–1207.
   PubMed Web of Science ®Google Scholar
• Millán, J. L. 1992. Alkaline phosphatase as a reporter of cancerous transformation. Clin. Chim. Acta 209:123–129.
   Google Scholar
• Millán, J. L. and Fishman, W. H. 1995. Biology of human alkaline phosphatases with special reference to cancer. Crit. Rev. Clin. Lab. Sci. 32:1–39.
   PubMed Web of Science ®Google Scholar
• Millán, J. L. (Ed.) 2006. Mammalian Alkaline Phosphatases–From Biology to Applications in Medicine and Biotechnology. Weinheim, Germany: Wiley-VCH.
   Google Scholar
• Moertel, C. G., Fleming, T. R., Macdonald, J. S., Haller, D. G., Laurie, J. A., Tangen, C. M., Ungerleider, J. S., Emerson, W. A., Tormey, D. C., Glick, J. H., Veeder, M. H. and Mailliard, J. A. 1995. Fluorouracil plus levamisole as effective adjuvant therapy after resection of Stage III colon carcinoma: a final report. Ann. Intern. Med. 122:321–326.
   PubMed Web of Science ®Google Scholar
• Mosmann, T. 1983. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 65:55–63.
   PubMed Web of Science ®Google Scholar
• Padmaja, K. and Ramanadham, M. 1998. Alkaline phosphatase activity is expressed in murine splenic B-lymphocytes sensitized in vivo with tetanus toxoid. Immunol. Lett. 61:175–178.
   PubMedGoogle Scholar
• Padmaja, K. 1999. Role of Alkaline Phosphatase in B-Lymphocyte Activation. University of Hyderabad. Hyderabad, India, Ph.D Thesis.
   Google Scholar
• Sanchez de Medina, F., Martinez-Augustin, O., Gonzalez, R., Ballester, I., Nieto, A., Galvez, J. and Zarzuelo, A. 2004. Induction of alkaline phosphatase in the inflamed intestine: A novel pharmacological target for inflammatory bowel disease. Biochem. Pharmacol. 68:2317–2326.
   PubMed Web of Science ®Google Scholar
• Wei, J. S., Chung, N. C., Wei, L. L., Tzeng, W. F., Liu, T. Z. and Wang, J. Y. 1993. High-molecular-mass alkaline phosphatase as a tumor marker for colorectal cancer: Comparison of two test methods. Clin. Chem. 39:540–543.
   PubMed Web of Science ®Google Scholar
• Yip, D., Strickland, A. H., Karapetis, C. S., Hawkins, C. A. and Harper, P. G. 2000. Immunomodulation therapy in colorectal carcinoma. Cancer Treat. Rev. 26:169–190.
   PubMed Web of Science ®Google Scholar